Trials / Completed
CompletedNCT06718478
First in Human Study of SakuraBead for Genicular Artery Embolization to Treat Pain Secondary to Knee Osteoarthritis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- CrannMed · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, single-centre, single-arm, unmasked, First in Human study that aims to evaluate the safety and efficacy of SakuraBead resorbable microspheres in adult patients suffering from pain secondary to knee osteoarthritis.
Detailed description
To evaluate safety and efficacy of SakuraBead for the treatment of pain secondary to knee osteoarthritis. Treatment will be performed on up to 15 patients who will be followed up for a period of 6 months.
Conditions
- Osteoarthritis (OA) of the Knee
- Osteoarthritis Knee Pain
- Joint Diseases
- Musculoskeletal Diseases
- Rheumatic Diseases
- Arthritis
- Osteoarthritis
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SakuraBead Resorbable Microspheres | Temporary Embolization of Genicular Arteries using SakuraBead Resorbable Microspheres |
Timeline
- Start date
- 2023-12-05
- Primary completion
- 2024-03-28
- Completion
- 2024-08-23
- First posted
- 2024-12-05
- Last updated
- 2024-12-05
Locations
1 site across 1 country: Uzbekistan
Source: ClinicalTrials.gov record NCT06718478. Inclusion in this directory is not an endorsement.